heart-disease

Documents about heart-disease

• Advance Care Planning: A Way to Improve End-of-life Care Life Care#829534ClinicalTrials.gov
• Effect of CV4 and Rib Raising Techniques on Autonomic Balance#843584ClinicalTrials.gov
• NUTRITION MATTERS: A Food is Medicine Intervention for African-American Adults With Multiple Chronic Conditions#847669ClinicalTrials.gov
• Deportation Worry, Cardiovascular Disease Risk Factor Trajectories, and Incident Hypertension: A Community‐Based Cohort Study#609438eScholarship
• Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence#146295ClinicalTrials.gov
• 3D models and simulations training improves TEE performance on pediatric patients with simple valvular congenital heart disease compared to traditional apprenticeship training: a clinical randomized controlled trial.#162108NCBI PubMed Central
• Assessing the importance of sex and disease-specific anatomy in electrophysiology and mechanical simulations with a newly developed public virtual cohort of four-chamber heart models#273359Europe PMC
• Knowledge of ischemic heart disease risk factors among first-generation Indian migrants living in Australia: A cross-sectional survey#654744Research Online
• Atorvastatin to Treat Pulmonary Sarcoidosis#800214ClinicalTrials.gov
• Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness#825505ClinicalTrials.gov
• Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage#832296ClinicalTrials.gov
• Serum Magnesium Levels in Desalination Tap Water and Outcomes in Acute Myocardial Infarction Patients#842390ClinicalTrials.gov
• Effect of Remote Ischemic Preconditioning on Cognitive Function After Off-Pump Coronary Artery Bypass Graft#854339ClinicalTrials.gov
• Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)#126028ClinicalTrials.gov
• The Role of Background Activity Monitoring by Amplitude-Integrated EEG to Predict Short-Term Neurological Outcome in Neonates with Congenital Heart Disease: Insights from a Real-Life Retrospective Cohort.#140511NCBI PubMed Central
• The Australia and New Zealand Congenital Outcomes Registry for Surgery (ANZCORS): methodology and preliminary results#273695Figshare
• “Multimodal Neuromonitoring and Cerebral Autoregulation Assessment in Neonatal and Pediatric Intensive Care”#322653IRIS
• Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.#376102Repisalud
• Association of Low-Density Lipoprotein Cholesterol with Risk of Coronary Heart Disease and Stroke among Middle-Aged Japanese Workers: An Analysis using Inverse Probability Weighting#384220CiNii
• The Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion#448229ClinicalTrials.gov
• Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)#826875ClinicalTrials.gov
• NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers#832706ClinicalTrials.gov
• Meta-analysis of the Nordic Dietary Pattern on Cardiometabolic Risk and Cardiovascular Outcomes#846085ClinicalTrials.gov
• The Supporting Patient Activation in Transition to Home Intervention#851180ClinicalTrials.gov
• Substrate Mapping and Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease: How to Identify Ventricular Tachycardia Substrate#478671HAL (France)
• The relationship between prognostic nutritional index and in-hospital mortality in patients with severe coronary heart disease: A multicenter retrospective cohort study and predictive model based on machine learning.#678336NCBI PubMed Central
• Nitric Oxide During Bypass for Arterial Switch Operation#802488ClinicalTrials.gov
• EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease#835132ClinicalTrials.gov
• Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study#847494ClinicalTrials.gov
• Communication During Hospitalization About Resuscitation Trial#863380ClinicalTrials.gov
• Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions#847975ClinicalTrials.gov
• Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice#491763eScholarship
• Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology#642180eScholarship
• Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk#137492HAL (France)
• Examining the uptake, retention, and effectiveness of a national online type 2 diabetes self-management intervention in England (Healthy Living): A retrospective cohort study#255575PLOS
• Off-label use of Lifetech KONAR-MF™ ventricular septal defect occluder for large patent ductus arteriosus closure in <6 ​kg infants#257547HAL (France)
• Atrial fibrillatory rate and irregularity of ventricular response as predictors of clinical outcome in patients with atrial fibrillation#275059Lund University Publications
• Stress hyperglycemia ratio predicts mid- to long-term mortality in first-hospitalized type 2 diabetes: Nonlinear threshold and prognostic value#327588PLOS
• A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti#801632ClinicalTrials.gov
• Management of Patients With HF by Using Educational or Educational & Telephone or Telephone Interventions and Support in Cyprus#813683ClinicalTrials.gov
• Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol#839479ClinicalTrials.gov
• Socio-geographical factors associated with cardiac rehabilitation participation after percutaneous coronary intervention: A registry-based cohort study from France#153656HAL (France)
• Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.#805838ClinicalTrials.gov
• Healthy Communities: a Healthy City Preventive Program on Cardiovascular Health and Well-being (HC)#807178ClinicalTrials.gov
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management#839687ClinicalTrials.gov
• Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults#853557ClinicalTrials.gov
• Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics#677152HAL (France)
• Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents#801641ClinicalTrials.gov
• Clinical and Chemical Outcomes Following Cardiac Surgery: The Post-Operative Effects of MUF#806118ClinicalTrials.gov
• Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery#831243ClinicalTrials.gov